The current standard for a celiac disease diagnosis is a positive blood test for specific antibodies, followed by a biopsy of the intestine that reveals damage to the villi (villous atrophy). These tests are certainly invasive and unpleasant, but more than that, they are useless in cases where a patient is already following a gluten-free diet. These patients must then undergo a “gluten challenge” of up to eight weeks, during which time they reintroduce gluten-containing foods into their diet, and suffer the consequences. Only then will the blood test and biopsy accurately reveal the hallmarks necessary for an accurate diagnosis.
1/11/2018
New Testing Option for Possible Celiac Disease Sufferers
Recent Posts
- Celiac Disease Foundation Advances Research, Policy, and Global Patient Leadership at ICDS 2026
- Teva Pharmaceuticals Announces Positive Phase 2a Results for Investigational Celiac Disease Treatment
- The Emerald Benefit: A Shining Example of Celiac Disease Advocacy
- Advocacy Spotlight: The Power of Youth Advocates
Search the archive
Categories
- Advocacy News
- Celiac Disease in the News
- Clinical Trials
- Community Spotlight
- Eat! Gluten-Free
- Featured
- Foundation Press
- iCureCeliac
- Impact Fund
- Marilyn’s Message
- Monthly eNewsletter
- Patient Profile Advocacy Series
- Recipes
- Research
- Research News
- Trending Topics
Marilyn's Message
3/18/2025
Read moreA Bold New Look for the Celiac Disease Foundation